Laparoscopy instruments are witnessing a surge in demand due to the increasing adoption of minimally invasive surgeries (MIS) across various specialties, including general surgery, gynecology, and urology. These procedures offer advantages such as faster recovery, lower risk of infection, and reduced hospital stays
According to Fortune Business Insights, the laparoscopy instruments market was valued at USD 15.24 billion in 2023. It is projected to grow from USD 16.48 billion in 2024 to USD 30.71 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period. In 2023, North America dominated the laparoscopy instruments market, accounting for a market share of 50.92%.
🔍 Key Market Trends:
- Technological Advancements: Integration of energy devices, smart visualization tools, and ergonomic designs are enhancing surgical precision.
- Rise in Outpatient Surgeries: Growing preference for day-care surgical procedures is fueling the demand for compact and disposable laparoscopic tools.
- Emerging Markets Growth: Developing countries are experiencing rising investments in healthcare infrastructure, boosting laparoscopic adoption.
- Robotic-Assisted Surgery Integration: Robotics is playing a crucial role in improving surgical outcomes and expanding the scope of laparoscopy.
Top Companies in the Market
- Microline Surgical (U.S.)
- KARL STORZ SE & Co. KG (Germany)
- BD (U.S.)
- Medtronic (Ireland)
- CONMED Corporation (U.S.)
- Olympus Corporation (Japan)
- Erbe Elektromedizin GmbH (Germany)
- Stryker (U.S.)
- ETHICON (Johnson & Johnson Services, Inc.) (U.S.)
- LIVSMED, INC. (South Korea)
